Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial.
Solomón MT, Selva JC, Figueredo J, Vaquer J, Toledo C, Quintanal N, Salva S, Domíngez R, Alert J, Marinello JJ, Catalá M, Griego MG, Martell JA, Luaces PL, Ballesteros J, de-Castro N, Bach F, Crombet T. Solomón MT, et al. Among authors: luaces pl. BMC Cancer. 2013 Jun 19;13:299. doi: 10.1186/1471-2407-13-299. BMC Cancer. 2013. PMID: 23782513 Free PMC article. Clinical Trial.
Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck.
Rodríguez MO, Rivero TC, del Castillo Bahi R, Muchuli CR, Bilbao MA, Vinageras EN, Alert J, Galainena JJ, Rodríguez E, Gracias E, Mulén B, Wilkinson B, de Armas EL, Pérez K, Pineda I, Frómeta M, Leonard I, Mullens V, Viada C, Luaces P, Torres O, Iznaga N, Crombet T. Rodríguez MO, et al. Cancer Biol Ther. 2010 Mar 1;9(5):343-9. doi: 10.4161/cbt.9.5.10981. Epub 2010 Mar 20. Cancer Biol Ther. 2010. PMID: 20448462 Clinical Trial.
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients.
Rodriguez PC, Neninger E, García B, Popa X, Viada C, Luaces P, González G, Lage A, Montero E, Crombet T. Rodriguez PC, et al. J Immune Based Ther Vaccines. 2011 Oct 24;9:7. doi: 10.1186/1476-8518-9-7. J Immune Based Ther Vaccines. 2011. PMID: 22024351 Free PMC article.
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.
Evans R, Lee K, Wallace PK, Reid M, Muhitch J, Dozier A, Mesa C, Luaces PL, Santos-Morales O, Groman A, Cedeno C, Cinquino A, Fisher DT, Puzanov I, Opyrchal M, Fountzilas C, Dai T, Ernstoff M, Attwood K, Hutson A, Johnson C, Mazorra Z, Saavedra D, Leon K, Lage A, Crombet T, Dy GK. Evans R, et al. Among authors: luaces pl. Front Oncol. 2022 Aug 3;12:958043. doi: 10.3389/fonc.2022.958043. eCollection 2022. Front Oncol. 2022. PMID: 35992783 Free PMC article.
Hematological, biochemical, respiratory, cardiovascular and electroneurophysiological parameters in African green monkeys (Cercopithecus aethiops sabaeus). Its use in non-clinical toxicological studies.
Casacó A, Beausoleil I, Gonzalez B, Luaces P, León A, Arteaga ME, Prado P, Rodríguez V, Pérez A, Guevara G, Bada AM, Ledón N, Fuentes D, González C, Hernandez O, Orphee R, Blanco D, García-Osuma M, Ballester-Labrada A. Casacó A, et al. J Med Primatol. 2010 Jun;39(3):177-86. doi: 10.1111/j.1600-0684.2010.00410.x. Epub 2010 Mar 12. J Med Primatol. 2010. PMID: 20345770